Picture of THC Biomed Intl logo

THC THC Biomed Intl Income Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro Cap

Annual income statement for THC Biomed Intl, fiscal year end - July 31st, CAD millions except per share, conversion factor applied.

2018
July 31st
2019
July 31st
2020
July 31st
2021
July 31st
2022
July 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue0.9251.494.183.773.34
Cost of Revenue
Gross Profit0.5221.53.24-3.17-1.03
Selling / General / Administrative Expenses
Depreciation and Amortization
Operating Interest Expense / Income
Unusual Expense / Income
Total Operating Expenses3.496.344.3110.17
Operating Profit-2.57-4.85-0.13-6.33-3.66
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-12.5-12.7-0.162-6.36-3.07
Net Income After Taxes-12.5-12.7-0.162-6.36-3.07
Net Income Before Extraordinary Items
Net Income-12.5-12.7-0.162-6.36-3.07
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-12.5-12.7-0.162-6.36-3.07
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.11-0.096-0.001-0.039-0.021